Related Subjects:
|Wolff-Parkinson White syndrome (WPW) AVRT
|Lown Ganong Levine Syndrome AVRT
|Supraventricular Tachycardia (SVT)
|Atrioventricular Nodal Reentrant Tachycardia AVNRT
|Atrial Flutter
|Atrial Fibrillation
|Sinus Tachycardia
|Sinus Arrhythmia
|Multifocal Atrial Tachycardia
|Resuscitation - Adult Tachycardia Algorithm
Important: Class I and III antiarrhythmic drugs should not be administered until the heart rate is controlled using digoxin, beta-blockers, or calcium channel blockers. These drugs can slow the flutter rate, potentially leading to dangerous 1:1 conduction. Catheter ablation, which targets the reentrant circuit responsible for typical atrial flutter, has a success rate exceeding 90% in preventing recurrence.
About Atrial Flutter
- Atrial flutter is an atrial arrhythmia characterized by a rapid atrial rate of 280–350 beats per minute.
- Always suspect atrial flutter if the ventricular rate is approximately 150 beats per minute, especially in patients with no evidence of accessory pathways.
- Commonly associated with atrial fibrillation, and patients may alternate between the two rhythms (atrial fibrillation–flutter).
Aetiology
- Atrial flutter is a macro-reentrant arrhythmia typically involving the right atrium.
- May occur in structurally normal hearts or be associated with underlying cardiac or systemic conditions.
- Risk factors include prior atrial fibrillation, hypertension, coronary artery disease, and valvular heart disease.
ECG Appearances
ECG Findings
- Sawtooth Pattern: A characteristic sawtooth appearance of atrial activity, often best seen in the inferior leads (II, III, aVF).
- 1:1 AV Conduction: Ventricular rate of 300 bpm (rare but life-threatening due to reduced cardiac output).
- 2:1 AV Block: Ventricular rate of 150 bpm (most common presentation).
- 3:1 AV Block: Ventricular rate of 100 bpm.
- 4:1 AV Block: Ventricular rate of 75 bpm.
- Carotid sinus massage or adenosine can transiently increase AV block, making flutter waves more apparent.
Types of Atrial Flutter
- Type I (Typical): Caused by a macro-reentrant tachycardia circuit within the right atrium, usually around the tricuspid annulus (cavo-tricuspid isthmus dependent).
- Type II (Atypical): Involves non-cavo-tricuspid isthmus-dependent circuits and is often associated with prior atrial surgery or ablation.
Causes
- Idiopathic atrial flutter
- Pulmonary embolism
- Atrial septal defect
- Ischaemic heart disease
- Hypertension
- Cardiomyopathy
- Chronic obstructive pulmonary disease (COPD)
- Post-cardiac surgery
- Pericarditis
- Thyrotoxicosis
- Alcohol intoxication ("holiday heart syndrome")
Clinical Presentation
- May be asymptomatic, especially if the ventricular rate is well controlled.
- Common symptoms include palpitations, fatigue, shortness of breath, dizziness, or lightheadedness.
- Severe cases may present with hemodynamic instability, syncope, or heart failure symptoms.
Investigations
- Blood Tests: FBC, U&E, TFTs, CRP. Troponin and BNP levels may also help assess for cardiac stress or failure.
- ECG: Essential for diagnosis. Suspect atrial flutter in tachyarrhythmias with a ventricular rate of 150 bpm. Adenosine or carotid sinus massage may help unmask flutter waves.
- Echocardiogram: Evaluate left ventricular function, atrial size, valve pathology, and potential structural abnormalities.
- Holter Monitoring: Useful for detecting intermittent atrial flutter or related arrhythmias.
Management: See below
- Synchronized DC Cardioversion: First-line treatment for patients who are hemodynamically unstable.
- Rate Control: Achieved using beta-blockers, calcium channel blockers, or digoxin.
- Rhythm Control: Amiodarone or flecainide can help restore sinus rhythm, but caution is needed due to the risk of 1:1 conduction.
- Catheter Ablation: Gold-standard treatment for long-term management, with a high success rate for preventing recurrence.
- Anticoagulation: Assess stroke risk using CHA₂DS₂-VASc score and consider anticoagulation to reduce thromboembolic risk.
- Adjunctive Measures: Lifestyle modifications, including limiting alcohol intake and treating underlying conditions such as COPD or thyrotoxicosis, are essential for long-term management.
Contraindicated Drugs in Atrial Flutter
-
Class I Antiarrhythmics (e.g., Flecainide, Propafenone):
- Reason: These drugs can slow the atrial flutter rate without blocking conduction to the ventricles, increasing the risk of 1:1 atrioventricular (AV) conduction and dangerously high ventricular rates (e.g., 300 bpm).
- Exception: May be used cautiously in combination with an AV nodal blocking agent (e.g., beta-blockers, calcium channel blockers) to prevent 1:1 conduction.
-
Class III Antiarrhythmics (e.g., Amiodarone, Sotalol):
- Reason: Like Class I drugs, these can slow atrial flutter rate, potentially facilitating 1:1 conduction if AV nodal conduction is intact.
- Amiodarone Exception: May be used in specific situations but requires AV nodal blockade for safety.
Drugs to Use With Caution
-
Beta-Blockers (e.g., Metoprolol, Bisoprolol):
- Caution: Effective for rate control, but excessive doses can lead to bradycardia or hypotension, especially in combination with other rate-limiting agents.
-
Non-Dihydropyridine Calcium Channel Blockers (e.g., Verapamil, Diltiazem):
- Caution: Effective for rate control, but avoid in patients with decompensated heart failure or significant systolic dysfunction due to negative inotropic effects.
References